JPI Antimicrobial Resistance

The overall aim of the Joint Programming process is to pool national research efforts in order to make better use of Europe's precious public R&D resources and to tackle common European challenges more effectively in a few key areas. It is a structured and strategic process whereby Member States agree, on a voluntary basis and in a partnership approach, on common visions and Strategic Research Agendas (SRA) to address major societal challenges. JPIAMR objectives are: • Find routes for novel antibiotics and new anti-infectious strategies. • Scientifically validate means to increase the number of patients treated early with the appropriate antimicrobial. • Provide scientific evidence on ways to reduce the spread of resistant strains. • Provide scientific evidence on strategies to reduce the number of patients with resistant or MDR strains, at any level of antibiotic consumption. • Reduce the consumption of antibiotics. JPIAMR participating countries are: Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Israel, Italy, Netherlands, Norway, Poland, Romania, Spain, Sweden, Switzerland, Turkey, UK. JPIAMR will launch each year one or more calls to finance specific projects.